Cogent Biosciences Inc (COGT)
7.52
+0.23
(+3.16%)
USD |
NASDAQ |
May 03, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.312M |
| June 30, 2020 | 0.528M |
| March 31, 2020 | 7.031M |
| December 31, 2019 | 15.29M |
| September 30, 2019 | 1.02M |
| June 30, 2019 | 3.138M |
| March 31, 2019 | 3.053M |
| December 31, 2018 | 3.805M |
| Date | Value |
|---|---|
| September 30, 2018 | 2.043M |
| June 30, 2018 | 1.666M |
| March 31, 2018 | 2.22M |
| December 31, 2017 | 2.123M |
| September 30, 2017 | 2.331M |
| June 30, 2017 | 2.079M |
| March 31, 2017 | 1.827M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.312M
Minimum
Sep 2020
15.29M
Maximum
Dec 2019
4.553M
Average
2.079M
Median
Revenue (Quarterly) Benchmarks
| QuidelOrtho Corp | 742.60M |
| NeuroOne Medical Technologies Corp | 0.9776M |
| Agios Pharmaceuticals Inc | 7.103M |
| Tenon Medical Inc | 0.808M |
| DIH Holding US Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.36M |
| Total Expenses (Quarterly) | 58.23M |
| EPS Diluted (Quarterly) | -0.63 |
| Enterprise Value | 491.35M |
| Earnings Yield | -32.05% |
| Normalized Earnings Yield | -33.84 |